Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(4.14)
# 382
Out of 5,178 analysts
22
Total ratings
47.83%
Success rate
23.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Maintains: Buy | $60 → $110 | $34.30 | +220.75% | 5 | Mar 25, 2026 | |
| GPCR Structure Therapeutics | Maintains: Buy | $114 → $100 | $46.75 | +113.90% | 4 | Mar 16, 2026 | |
| DYN Dyne Therapeutics | Maintains: Buy | $60 → $50 | $18.84 | +165.39% | 3 | Mar 3, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $37 | $21.68 | +70.66% | 2 | Feb 3, 2026 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $50 | $32.68 | +53.00% | 1 | Dec 15, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $5.13 | +289.86% | 3 | Nov 13, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $6.00 | +300.00% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $0.62 | +3,151.50% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $5.04 | +178.05% | 1 | Aug 15, 2025 |
Maze Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $60 → $110
Current: $34.30
Upside: +220.75%
Structure Therapeutics
Mar 16, 2026
Maintains: Buy
Price Target: $114 → $100
Current: $46.75
Upside: +113.90%
Dyne Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $60 → $50
Current: $18.84
Upside: +165.39%
ACADIA Pharmaceuticals
Feb 3, 2026
Reiterates: Buy
Price Target: $37
Current: $21.68
Upside: +70.66%
Stoke Therapeutics
Dec 15, 2025
Maintains: Buy
Price Target: $35 → $50
Current: $32.68
Upside: +53.00%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $5.13
Upside: +289.86%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $6.00
Upside: +300.00%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $0.62
Upside: +3,151.50%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $5.04
Upside: +178.05%